|Chemical and physical data|
|Molar mass||194.954 g/mol g·mol−1|
|3D model (JSmol)|
Halopropane (synonym FHD-3, trade name Tebron) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed. Its clinical development was terminated due to a high incidence of cardiac arrhythmias in patients, similarly to the cases of teflurane and norflurane.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|